Page last updated: 2024-08-24

thiazolyl blue and crenolanib

thiazolyl blue has been researched along with crenolanib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortes, J; Galanis, A; Levis, M; Ma, H; Rajkhowa, T; Ramachandran, A; Small, D1

Trials

1 trial(s) available for thiazolyl blue and crenolanib

ArticleYear
Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants.
    Blood, 2014, Jan-02, Volume: 123, Issue:1

    Topics: Antineoplastic Agents; Benzimidazoles; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Piperidines; Point Mutation; Prognosis; Proto-Oncogene Proteins c-kit; Sequence Analysis, DNA; Tetrazolium Salts; Thiazoles; Time Factors

2014
chemdatabank.com